Clinical Trials Sponsored by Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute of New Jersey

Total 50 results

Christian Hinrichs
National Cancer Institute (NCI); Cancer Immunology and Metabolism Center of...

Recruiting

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Cervical Cancer | Breast Cancer | Gastric Cancer | Lung Cancer

United States
University of Medicine and Dentistry of New Jersey
Bristol-Myers Squibb; Rutgers Cancer Institute of New Jersey

Terminated

First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

Colorectal Cancer

United States
University of Medicine and Dentistry of New Jersey
Robert Wood Johnson Foundation; Rutgers Cancer Institute of New Jersey

Completed

Combination Medications vs. Patch Alone for Medically-Ill Smokers

Smoking Cessation

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditions

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin

Carcinoma of Unknown Primary

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Cervical Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Sulindac and Plant Compounds in Preventing Colon Cancer

Colorectal Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Kidney Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

Prostate Cancer | Osteoporosis

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Internet Use Among Women With Recurrent Metastatic Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Withdrawn

Collecting and Storing Blood Samples From Patients With Cancer

Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Nonmalignant Neoplasm | Lymphoproliferative Disorder and other conditions
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation

Lymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease

Lymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Dextromethorphan in Treating Patients With Fatigue Caused by Cancer

Unspecified Childhood Solid Tumor, Protocol Specific | Fatigue | Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Completed

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Precancerous/Nonmalignant Condition

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Melanoma (Skin)

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Sanofi

Withdrawn

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

Hyperglycemia | Leukemia

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; University... and other collaborators

Recruiting

Bright IDEAS - Young Adults Problem-Solving Skills Training

Cancer Patients | Supportive Care | Young Adult

United States
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaborators

Completed

Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

Prostate Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Novartis Pharmaceuticals

Completed

Phase I Study of Patupilone and RAD001

Refractory Malignancy

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Aventis Pharmaceuticals

Terminated

Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer

Breast Cancer

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Aventis Pharmaceuticals

Terminated

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Department of Health and Human Services; Penn... and other collaborators

Active, not recruiting

Estrogen, Diet, Genetics and Endometrial Cancer

Cancer | Ovarian Cancer | Endometrial Cancer | Endometrium | Corpus Uteri

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Genentech, Inc.; Schering-Plough

Withdrawn

QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC

Lung Cancer | Metastatic Cancer
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Massachusetts General Hospital; Fox Chase Cancer... and other collaborators

Completed

Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients

Cancer | Colorectal | Intervention | Screening

United States
Brigham and Women's Hospital
National Cancer Institute (NCI); Dana-Farber Cancer Institute; University of... and other collaborators

Recruiting

A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation (Potlako+)

Neoplasms | Cervical Cancer | Breast Cancer | Hiv | Vulvar Cancer | Anal Cancer | HNSCC | Cancer Suspect

Botswana
Rutgers, The State University of New Jersey
The University of Texas Health Science Center at San Antonio; Health Resources...

Completed

Remote Ischemic Preconditioning in Neurological Death Organ Donors (RIPNOD)

Organ Transplantation

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Columbia... and other collaborators

Completed

Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial (P-SCIP)

Childhood Cancers

United States
Vanderbilt University
Patient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Emory... and other collaborators

Completed

Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer (CEASAR)

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
University of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaborators

Completed

3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

Prostate Cancer

United States
Foundation Medicine
Johns Hopkins University; Memorial Sloan Kettering Cancer Center; University... and other collaborators

Completed

Concordance Between ctDNA Assay and FoundationOne

Neoplasms | Cancer | Circulating Tumor DNA | Genomic Testing | Genomic Alterations

United States
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; M.D. Anderson Cancer Center; Dana-Farber Cancer Institute and other collaborators

Active, not recruiting

Molecular Studies and Clinical Correlations in Human Prostatic Disease

Prostate Cancer

United States
Baylor Research Institute
Medical University of South Carolina; University of Alabama at Birmingham; University... and other collaborators

Completed

Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

End Stage Liver Disease | Hepatitis C

United States
Brigham and Women's Hospital
Johns Hopkins University; University of Colorado, Denver; Mayo Clinic; Baylor College... and other collaborators

Completed

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 (STOP-COVID)

Coronavirus Infection

United States
Beth Israel Deaconess Medical Center
Medical University of South Carolina; Johns Hopkins University; University Health... and other collaborators

Recruiting

Statins In Intracerbral Hemorrhage (SATURN)

Intracerebral Hemorrhage

United States
Children's Hospital Medical Center, Cincinnati
Mayo Clinic; University of California, Los Angeles; University of Alabama at... and other collaborators

Recruiting

Pediatric Obesity Weight Evaluation Registry (POWER) Study (POWER)

Obesity | Overweight

United States
University of Alabama at Birmingham
Medical University of South Carolina; Johns Hopkins University; University of... and other collaborators

Completed

Chronic Hypertension and Pregnancy (CHAP) Project (CHAP)

Hypertension

United States
The Society for Pediatric Anesthesia
Medical University of South Carolina; Johns Hopkins University; Baylor College... and other collaborators

Recruiting

The Pediatric Anesthesia Quality Improvement Project (WUS)

Children | Surgery | Anesthesia

United States

Clinical Trials Sponsored by Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute of New Jersey

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations